AMY AKAIKE, MBA, PMP, is the Ethics & Compliance Officer for the Japan Affiliate of Eli Lilly & Co. She serves on the Executive Board of Eli Lilly Japan and is also a member of Lilly Corporate Ethics & Compliance Leadership Team. Her responsibility is to partner with all parts of the organization and influence strategies to drive integration of high performance with high integrity. In the past two years, Amy led a major transformation effort at the Japan Affiliate through policy redesign, global integration and establishment of governance overseeing integrity agendas across functions.
Prior to her current capacity, Amy assumed leadership roles in Japan and US in pharmaceutical R&D portfolio management, strategic information, decision sciences, alliance management, drug development in oncology, neuroscience and critical care, project management, business operations, and most recently had responsibility for Six Sigma deployment across the pharmaceutical value chain from Drug Development, Product Quality, Manufacturing, General Services and Sales & Marketing. Amy has a Bachelor degree in Biology from ICU, Tokyo, and an MBA from IMD, Lausanne Switzerland.